Guillain-Barré syndrome other diagnostic studies

Guillain-Barré syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Guillain-Barré syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural history, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Guillain-Barré syndrome other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Guillain-Barré syndrome other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Guillain-Barré syndrome other diagnostic studies
CDC on Guillain-Barré syndrome other diagnostic studies
Guillain-Barré syndrome other diagnostic studies in the news
Blogs on Guillain-Barré syndrome other diagnostic studies
Directions to Hospitals Treating Guillain-Barré syndrome
Risk calculators and risk factors for Guillain-Barré syndrome other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]

Overview

Guillain-Barré syndrome (GBS) is an acute, autoimmune, polyradiculoneuropathy affecting the peripheral nervous system, usually triggered by an acute infectious process. Nerve conduction study may show prolonged distal latencies, conduction slowing, conduction block, and temporal dispersion of compound action potential in demyelinating cases.

Other diagnostic studies

ECD is used almost every time to verify symptoms, but because of the acute nature of the disease, they may not become abnormal until after the first week of onset of signs and symptoms. The following tests may be ordered:

• Electrodiagnostics -
  • Electromyography (EMG)-EMG tests the electrical activity in muscles. It may show that nerves do not react properly to stimulation.
  • Nerve conduction study
    • (NCS) may show prolonged distal latencies, conduction slowing, conduction block, and temporal dispersion of compound action potential in demyelinating cases.
    • In primary axonal damage, the findings include reduced amplitude of the action potentials without conduction slowing.
    • Nerve motor action potentials may be decreased. Compound muscle action potential (CMAP) amplitude may be decreased.
    • The extent of decreased action potentials correlates with prognosis. Prolonged distal latencies may be present. Abnormal H-reflex may be noted.
    • Needle examination shows profuse and early denervation potentials also support the conclusion that there has been axonal injury